acyclovir

Generic: acyclovir

Labeler: atlantic biologicals corp.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acyclovir
Generic Name acyclovir
Labeler atlantic biologicals corp.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

acyclovir 200 mg/5mL

Manufacturer
ATLANTIC BIOLOGICALS CORP.

Identifiers & Regulatory

Product NDC 17856-0083
Product ID 17856-0083_34f331d6-af84-69ea-e063-6394a90ae36e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA074738
Listing Expiration 2026-12-31
Marketing Start 2002-09-03

Pharmacologic Class

Established (EPC)
herpes simplex virus nucleoside analog dna polymerase inhibitor [epc] herpes zoster virus nucleoside analog dna polymerase inhibitor [epc] herpesvirus nucleoside analog dna polymerase inhibitor [epc]
Mechanism of Action
dna polymerase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 178560083
Hyphenated Format 17856-0083

Supplemental Identifiers

RxCUI
307730
UNII
X4HES1O11F
NUI
N0000020060 N0000180187 N0000180188 N0000175468 N0000175459

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acyclovir (source: ndc)
Generic Name acyclovir (source: ndc)
Application Number ANDA074738 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/5mL
source: ndc
Packaging
  • 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0083-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0083-4)
  • 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0083-2) / 10 mL in 1 CUP, UNIT-DOSE (17856-0083-3)
source: ndc

Packages (2)

17856-0083-1 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0083-1) / 5 mL in 1 CUP, UNIT-DOSE (17856-0083-4) 17856-0083-2 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0083-2) / 10 mL in 1 CUP, UNIT-DOSE (17856-0083-3)

Ingredients (1)

acyclovir (200 mg/5mL)

Linked Drug Pages (1)

Acyclovir ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "34f331d6-af84-69ea-e063-6394a90ae36e", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["307730"], "spl_set_id": ["da5a809c-6ddc-4609-9a34-ccb3d2d43976"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["ATLANTIC BIOLOGICALS CORP."]}, "finished": true, "packaging": [{"sample": false, "description": "72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0083-1)  / 5 mL in 1 CUP, UNIT-DOSE (17856-0083-4)", "package_ndc": "17856-0083-1", "marketing_start_date": "20240416"}, {"sample": false, "description": "72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0083-2)  / 10 mL in 1 CUP, UNIT-DOSE (17856-0083-3)", "package_ndc": "17856-0083-2", "marketing_start_date": "20240416"}], "brand_name": "Acyclovir", "product_id": "17856-0083_34f331d6-af84-69ea-e063-6394a90ae36e", "dosage_form": "SUSPENSION", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "17856-0083", "generic_name": "Acyclovir", "labeler_name": "ATLANTIC BIOLOGICALS CORP.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/5mL"}], "application_number": "ANDA074738", "marketing_category": "ANDA", "marketing_start_date": "20020903", "listing_expiration_date": "20261231"}